TY - JOUR
T1 - Structural basis of organic cation transporter-3 inhibition
AU - Khanppnavar, Basavraj
AU - Maier, Julian
AU - Herborg, Freja
AU - Gradisch, Ralph
AU - Lazzarin, Erika
AU - Luethi, Dino
AU - Yang, Jae Won
AU - Qi, Chao
AU - Holy, Marion
AU - Jäntsch, Kathrin
AU - Kudlacek, Oliver
AU - Schicker, Klaus
AU - Werge, Thomas
AU - Gether, Ulrik
AU - Stockner, Thomas
AU - Korkhov, Volodymyr M.
AU - Sitte, Harald H.
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022
Y1 - 2022
N2 - Organic cation transporters (OCTs) facilitate the translocation of catecholamines, drugs and xenobiotics across the plasma membrane in various tissues throughout the human body. OCT3 plays a key role in low-affinity, high-capacity uptake of monoamines in most tissues including heart, brain and liver. Its deregulation plays a role in diseases. Despite its importance, the structural basis of OCT3 function and its inhibition has remained enigmatic. Here we describe the cryo-EM structure of human OCT3 at 3.2 Å resolution. Structures of OCT3 bound to two inhibitors, corticosterone and decynium-22, define the ligand binding pocket and reveal common features of major facilitator transporter inhibitors. In addition, we relate the functional characteristics of an extensive collection of previously uncharacterized human genetic variants to structural features, thereby providing a basis for understanding the impact of OCT3 polymorphisms.
AB - Organic cation transporters (OCTs) facilitate the translocation of catecholamines, drugs and xenobiotics across the plasma membrane in various tissues throughout the human body. OCT3 plays a key role in low-affinity, high-capacity uptake of monoamines in most tissues including heart, brain and liver. Its deregulation plays a role in diseases. Despite its importance, the structural basis of OCT3 function and its inhibition has remained enigmatic. Here we describe the cryo-EM structure of human OCT3 at 3.2 Å resolution. Structures of OCT3 bound to two inhibitors, corticosterone and decynium-22, define the ligand binding pocket and reveal common features of major facilitator transporter inhibitors. In addition, we relate the functional characteristics of an extensive collection of previously uncharacterized human genetic variants to structural features, thereby providing a basis for understanding the impact of OCT3 polymorphisms.
U2 - 10.1038/s41467-022-34284-8
DO - 10.1038/s41467-022-34284-8
M3 - Journal article
C2 - 36344565
AN - SCOPUS:85141526608
VL - 13
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
IS - 1
M1 - 6714
ER -